Elicio Therapeutics ELTX
NASDAQ ELTX
$1.67 +0.10 (+6.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Debt Ratio (2020 - 2026)

Updated

Elicio Therapeutics' (ELTX) Debt Ratio came in at 0.30 for Q2 2026, down 3.8% from 0.32 a year earlier and down 27.1% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Debt Ratio (2020 - 2026) Analysis & Trends

For FY2025, Elicio Therapeutics' Debt Ratio stood at 0.36, down 48.8% from FY2024.

  • In prior years, Elicio Therapeutics' Debt Ratio was 0.71 in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Debt Ratio since Q1 2021.
  • According to Business Quant data, Debt Ratio for the three prior quarters was 0.42 (Q1 2026), 0.36 (Q4 2025) and 0.34 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Elicio Therapeutics 31.85 Mn -45.77 Mn - 0.30
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.30
Mar 31, 2026 0.42
Dec 31, 2025 0.36
Sep 30, 2025 0.34
Jun 30, 2025 0.32
Dec 31, 2024 0.71
Mar 31, 2021 0.01
Dec 31, 2020 1.09
API Access

Elicio Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ELTX&period=max&api_key=YOUR_API_KEY